Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells.

被引：0
|
作者：
Wang, ZY
Miura, N
Bonelli, A
Mole, P
Carlesso, N
Scadden, DT
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, AIDS Res Ctr, Boston, MA USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Canc Ctr, Boston, MA USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
279
引用
收藏
页码：68A / 68A
页数：1
相关论文
共 50 条
  • [41] Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers (vol 73, pg 184, 2013)
    Hasina, R.
    Mollberg, N.
    Kawada, I
    Mutreja, K.
    Kanade, G.
    Yala, S.
    CANCER RESEARCH, 2013, 73 (14) : 4594 - 4594
  • [42] The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
    S R Kumar
    R Masood
    W A Spannuth
    J Singh
    J Scehnet
    G Kleiber
    N Jennings
    M Deavers
    V Krasnoperov
    L Dubeau
    F A Weaver
    A K Sood
    P S Gill
    British Journal of Cancer, 2007, 96 : 1083 - 1091
  • [43] Differential expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during human placental development
    Chennakesava, C. S.
    Di Santo, S.
    Ziemiecki, A.
    Schneider, H.
    Andres, A. -C.
    PLACENTA, 2006, 27 (9-10) : 959 - 967
  • [44] The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization
    Yang, Nai-Ying
    Pasquale, Elena B.
    Owen, Laurie B.
    Ethell, Iryna M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (43) : 32574 - 32586
  • [45] Chimeric Antigen Receptor T Cells Redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma
    Yagyu, Shigeki
    Nakamura, Kayoko
    Morita, Daisuke
    Tanaka, Miyuki
    Kikuchi, Ken
    Iehara, Tomoko
    Nakazawa, Yozo
    Hosoi, Hajime
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S21 - S22
  • [46] Chimeric Antigen Receptor T Cells Redirecting EPHB4 for the Treatment of Human Rhabdomyosarcoma
    Yagyu, Shigeki
    Nakamura, Kayoko
    Morita, Daisuke
    Tanaka, Miyuki
    Kikuchi, Ken
    Iehara, Tomoko
    Hosoi, Hajime
    Nakazawa, Yozo
    MOLECULAR THERAPY, 2018, 26 (05) : 340 - 340
  • [47] THE EPHB4 RECEPTOR TYROSINE KINASE IN PROSTATE AND BREAST CANCER: NOVEL MECHANISMS OF ACTION VIA PROTEOLYSIS AND NUCLEAR TRANSLOCATION
    Herington, A. C.
    Lisle, J.
    Mertens-Walker, I.
    Stephens, C.
    Stansfield, S.
    Clements, J.
    Stephenson, S-A
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 : 11 - 11
  • [48] Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase
    Munarini, N
    Jäger, R
    Abderhalden, S
    Zuercher, G
    Rohrbach, V
    Loercher, S
    Pfanner-Meyer, B
    Andres, AC
    Ziemiecki, A
    JOURNAL OF CELL SCIENCE, 2002, 115 (01) : 25 - 37
  • [49] Nuclear localization of the receptor tyrosine kinase EphB4in prostate cancer cells
    Stephenson, Sally-Anne
    Mertens-Walker, Inga
    Lisle, Jessica
    Nyberg, William
    Stephens, Carson
    Burke, Leslie
    Rutkowski, Raphael
    Herington, Adrian
    BJU INTERNATIONAL, 2013, 112 : 50 - 51
  • [50] Structure-Based Optimization of Potent and Selective Inhibitors of the Tyrosine Kinase Erythropoietin Producing Human Hepatocellular Carcinoma Receptor B4 (EphB4)
    Lafleur, Karine
    Huang, Danzhi
    Zhou, Ting
    Caflisch, Amedeo
    Nevado, Cristina
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) : 6433 - 6446
12345